Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 2/20 | 0.36 |
| ▸ | CD22 | P20273 | 4/20 | 0.33 |
| ▸ | MAG | P20916 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15087684 | 1.00 | NANP (0.36) | NANPCD22MAGL3MBTL1 | |
| SCHEMBL15090338 | 0.81 | — | — | |
| SCHEMBL15087692 | 0.79 | CD22 (0.49) | CD22MAG | |
| SCHEMBL18733280 | 0.77 | L3MBTL1 (0.46) | NANPCD22MAGL3MBTL1 | |
| SCHEMBL19067256 | 0.77 | CD22 (0.42) | CD22MAG | |
| SCHEMBL18934900 | 0.77 | CD22 (0.42) | CD22MAG | |
| SCHEMBL14819158 | 0.77 | CD22 (0.42) | CD22MAG | |
| SCHEMBL29392242 | 0.76 | L3MBTL1 (0.42) | NANPCD22MAGL3MBTL1 | |
| SCHEMBL9699209 | 0.75 | L3MBTL1 (0.44) | NANPCD22MAGL3MBTL1 | |
| SCHEMBL1204652 | 0.75 | NANP (0.56) | NANPCD22MAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9260467-B2 | Sialic acid dimers | BROSSMER REINHARD (DE) | 2016-02-16 | — | — | US | disclosed |
| US-9260467-B2 | Sialic acid dimers | BROSSMER REINHARD (DE) | 2016-02-16 | — | — | US | disclosed |
| US-20150005245-A1 | Sialic Acid Dimers | BROSSMER REINHARD (DE) | 2015-01-01 | — | — | US | disclosed |
| US-20150005245-A1 | Sialic Acid Dimers | BROSSMER REINHARD (DE) | 2015-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150005245-A1 | Sialic Acid Dimers | SIGLEC9, SIGLEC7, NEU2 | NANP 333/4885CD22 20/4885MAG 503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.